Chlorosartan Hydrochlorothiazide Tablets can be used in combination with Levamlodipine Benzenesulfonate to have synergistic antihypertensive effect. Chlorosartan Hydrochlorothiazide Tablets is a compound preparation, the main ingredients are chlorosartan and hydrochlorothiazide. Adverse reactions include dizziness, diarrhea and allergy. It is contraindicated in patients who are allergic to any of the components of the drug, anuric, allergic to other sulfonamides, pregnant women. Levamlodipine benzenesulfonate is a calcium channel blocker that exerts antihypertensive effects by dilating peripheral blood vessels. Adverse reactions include headache, edema, fatigue, insomnia, nausea, abdominal pain, flushing, palpitations and dizziness. Patients with severe obstructive coronary artery disease, heart failure, patients with severe hepatic insufficiency, and patients with renal failure need to be contraindicated or used with caution. Chlorosartan hydrochlorothiazide and levamlodipine benzenesulfonate belong to different mechanisms of antihypertensive drugs, the simultaneous use of the combination can increase the effect of pressurization, the adverse effects will not increase significantly. Chlorosartan hydrochlorothiazide and benzenesulfonic acid levamlodipine combination process, pay attention to monitoring electrolyte changes, to avoid the emergence of hypokalemia, the specific treatment plan should follow the doctor’s instructions. Medications need to be applied as prescribed.